| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879718 | The Annals of Thoracic Surgery | 2008 | 8 Pages |
Abstract
This study demonstrated a mechanistic relationship between the ET-AR and tumor necrosis factor receptor activation in the post-cardiac surgery period. Thus, in addition to the potential cardiovascular effects, a selective ET-AR antagonist can modify other biological processes relevant to the post-cardiac surgery setting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rachael L. BS, Ira M. BS, Ebony J. BS, Scott T. MD, Robert E. MS, Fred A. MD, John S. MD, PhD, Francis G. MD, PhD,